The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...

A growing body of research suggests that mindfulness-based interventions may reduce stress, in turn helping to reduce ...

Heart disease claims more lives in America than any other medical problem every year, therefore keeping your heart and ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Guthrie officials said that cardiovascular diseases are the leading killer in the United States, but there are steps that ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

The founding director of the FDA’s Office of Biotechnology writes that new evidence suggests COVID may be a novel, additional ...

While common risk factors like high blood pressure, high cholesterol, obesity and smoking are well-known, there are other ...

Inside the devastating impact of heart disease on Black men in America - from healthcare barriers to community solutions, ...